• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化中的血小板减少症:纤维蛋白原对出血风险的影响。

Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding risk.

作者信息

Thakrar Sonali V, Mallett Susan V

机构信息

Sonali V Thakrar, Susan V Mallett, Royal Free Perioperative Research Group, Department of Anaesthesia, Royal Free London, London NW3 2QG, United Kingdom.

出版信息

World J Hepatol. 2017 Feb 28;9(6):318-325. doi: 10.4254/wjh.v9.i6.318.

DOI:10.4254/wjh.v9.i6.318
PMID:28293381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5332421/
Abstract

AIM

To investigate the relationship between baseline platelet count, clauss fibrinogen, maximum amplitude (MA) on thromboelastography, and blood loss in orthotopic liver transplantation (OLT).

METHODS

A retrospective analysis of our OLT Database (2006-2015) was performed. Baseline haematological indices and intraoperative blood transfusion requirements, as a combination of cell salvage return and estimation of 300 mls/unit of allogenic blood, was noted as a surrogate for intraoperative bleeding. Two groups: Excessive transfusion (> 1200 mL returned) and No excessive transfusion (< 1200 mL returned) were analysed. All data analyses were conducted using IBM SPSS Statistics version 23.

RESULTS

Of 322 OLT patients, 77 were excluded due to fulminant disease; redo transplant or baseline haemoglobin (Hb) of < 80 g/L. One hundred and fourteen (46.3%) were classified into the excessive transfusion group, 132 (53.7%) in the no excessive transfusion group. Mean age and gender distribution were similar in both groups. Baseline Hb ( ≤ 0.001), platelet count ( = 0.005), clauss fibrinogen ( = 0.004) and heparinase MA ( = 0.001) were all statistically significantly different. Univariate logistic regression with a cut-off of platelets < 50 × 10/L as the predictor and Haemorrhage as the outcome showed an odds ratio of 1.393 (95%CI: 0.758-2.563; = 0.286). Review of receiver operating characteristic curves showed an area under the curve (AUC) for platelet count of 0.604 (95%CI: 0.534-0.675; = 0.005) as compared with AUC for fibrinogen level, 0.678 (95%CI: 0.612-0.744; ≤ 0.001). A multivariate logistic regression shows United Kingdom model for End Stage Liver Disease ( = 0.006), Hb ( = 0.022) and Fibrinogen ( = 0.026) to be statistically significant, whereas Platelet count was not statistically significant.

CONCLUSION

Platelet count alone does not predict excessive transfusion. Additional investigations, ., clauss fibrinogen and viscoelastic tests, provide more robust assessment of bleeding-risk in thrombocytopenia and cirrhosis.

摘要

目的

探讨原位肝移植(OLT)中基线血小板计数、克劳斯纤维蛋白原、血栓弹力图最大振幅(MA)与失血之间的关系。

方法

对我们的OLT数据库(2006 - 2015年)进行回顾性分析。记录基线血液学指标和术中输血需求,将细胞回收量与每单位300毫升异体血估计量相结合,作为术中出血的替代指标。分析两组:过量输血组(回输量>1200毫升)和非过量输血组(回输量<1200毫升)。所有数据分析均使用IBM SPSS Statistics 23版进行。

结果

在322例OLT患者中,77例因暴发性疾病、再次移植或基线血红蛋白(Hb)<80克/升被排除。114例(46.3%)被分类为过量输血组,132例(53.7%)为非过量输血组。两组的平均年龄和性别分布相似。基线Hb(≤0.001)、血小板计数(=0.005)、克劳斯纤维蛋白原(=0.004)和肝素酶MA(=0.001)均有统计学显著差异。以血小板<50×10⁹/L为预测指标、出血为结果的单因素逻辑回归显示比值比为1.393(95%置信区间:0.758 - 2.563;=0.286)。对受试者工作特征曲线的回顾显示,血小板计数的曲线下面积(AUC)为0.604(95%置信区间:0.534 - 0.675;=0.005),而纤维蛋白原水平的AUC为0.678(95%置信区间:0.612 - 0.744;≤0.001)。多因素逻辑回归显示,英国终末期肝病模型(=0.006)、Hb(=0.022)和纤维蛋白原(=0.026)具有统计学显著性,而血小板计数无统计学显著性。

结论

仅血小板计数不能预测过量输血。其他检查,如克劳斯纤维蛋白原和粘弹性试验,能更可靠地评估血小板减少和肝硬化患者的出血风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1270/5332421/54ae24f4467e/WJH-9-318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1270/5332421/0eb77f1ff6be/WJH-9-318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1270/5332421/54ae24f4467e/WJH-9-318-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1270/5332421/0eb77f1ff6be/WJH-9-318-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1270/5332421/54ae24f4467e/WJH-9-318-g002.jpg

相似文献

1
Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding risk.肝硬化中的血小板减少症:纤维蛋白原对出血风险的影响。
World J Hepatol. 2017 Feb 28;9(6):318-325. doi: 10.4254/wjh.v9.i6.318.
2
Hemostatic Markers as Predictors of Massive Blood Transfusion in Orthotopic Liver Transplantation.止血标志物作为原位肝移植中大量输血的预测指标
Transplant Proc. 2022 Apr;54(3):734-737. doi: 10.1016/j.transproceed.2022.01.024. Epub 2022 Mar 4.
3
The Need for Red Cell Support During Non-Cardiac Surgery Is Associated to Pre-Transfusion Levels of FXIII and the Platelet Count.非心脏手术期间红细胞支持需求与输血前FXIII水平及血小板计数相关。
J Clin Med. 2020 Jul 31;9(8):2456. doi: 10.3390/jcm9082456.
4
Performance of functional fibrinogen thromboelastography in children undergoing congenital heart surgery.功能性纤维蛋白原血栓弹力图在先天性心脏病手术患儿中的应用
Paediatr Anaesth. 2017 Feb;27(2):181-189. doi: 10.1111/pan.13048. Epub 2016 Nov 30.
5
Impact of 6 % hydroxyethyl starch (HES) 130/0.4 on the correlation between standard laboratory tests and thromboelastography (TEG®) after cardiopulmonary bypass.6%羟乙基淀粉(HES)130/0.4对体外循环后标准实验室检查与血栓弹力图(TEG®)之间相关性的影响。
Thromb Res. 2015 May;135(5):984-9. doi: 10.1016/j.thromres.2015.02.006. Epub 2015 Feb 8.
6
Quantification of Both Platelet Count and Fibrinogen Concentration Using Maximal Clot Firmness of Thromboelastometry During Liver Transplantation.肝移植期间利用血栓弹力图的最大血凝块硬度对血小板计数和纤维蛋白原浓度进行定量分析。
Transplant Proc. 2015 Jul-Aug;47(6):1890-5. doi: 10.1016/j.transproceed.2015.02.019.
7
Rotational Thromboelastometry Rapidly Predicts Thrombocytopenia and Hypofibrinogenemia During Neonatal Cardiopulmonary Bypass.旋转血栓弹力图可快速预测新生儿体外循环期间的血小板减少症和低纤维蛋白原血症。
World J Pediatr Congenit Heart Surg. 2018 Jul;9(4):424-433. doi: 10.1177/2150135118771318.
8
Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.预防性血小板输注用于预防血液系统疾病患者化疗和干细胞移植后的出血。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD004269. doi: 10.1002/14651858.CD004269.pub3.
9
Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients.血栓弹力图可预测血小板减少患者发生2级出血的风险。
Vox Sang. 2017 Aug;112(6):578-585. doi: 10.1111/vox.12544. Epub 2017 Jun 22.
10
Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation.肝移植期间严重血小板减少症的治疗性而非预防性血小板输注策略。
Platelets. 2014;25(8):576-86. doi: 10.3109/09537104.2013.849335. Epub 2013 Nov 18.

引用本文的文献

1
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures.慢性肝脏疾病中的血小板减少症:侵入性操作前的病理生理学和新的治疗策略。
World J Gastroenterol. 2022 Aug 14;28(30):4061-4074. doi: 10.3748/wjg.v28.i30.4061.
2
Hemostasis testing in patients with liver dysfunction: Advantages and caveats.肝功能障碍患者的止血检测:优势和注意事项。
World J Gastroenterol. 2021 Nov 14;27(42):7285-7298. doi: 10.3748/wjg.v27.i42.7285.
3
Hemorrhage and complications associated with percutaneous ultrasound guided liver biopsy in dogs.

本文引用的文献

1
AAGBI guidelines: the use of blood components and their alternatives 2016.AAGBI 指南:血液成分及其替代品的使用 2016 年版。
Anaesthesia. 2016 Jul;71(7):829-42. doi: 10.1111/anae.13489. Epub 2016 Apr 8.
2
Reducing transfusion requirements in liver transplantation.减少肝移植中的输血需求。
World J Transplant. 2015 Dec 24;5(4):165-82. doi: 10.5500/wjt.v5.i4.165.
3
Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation.肝移植术中的失血、出血预测因素、输血实践及血细胞回收策略
犬经皮超声引导肝脏活检相关的出血及并发症。
J Vet Intern Med. 2020 Nov;34(6):2398-2404. doi: 10.1111/jvim.15942. Epub 2020 Oct 30.
4
Transfusion strategies in patients with cirrhosis.肝硬化患者的输血策略。
Eur J Haematol. 2020 Jan;104(1):15-25. doi: 10.1111/ejh.13342. Epub 2019 Nov 19.
5
ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs.ACVIM 共识声明:犬慢性肝炎的诊断与治疗。
J Vet Intern Med. 2019 May;33(3):1173-1200. doi: 10.1111/jvim.15467. Epub 2019 Mar 7.
6
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).芦曲泊帕治疗接受有创操作的慢性肝病患者血小板减少症(L-PLUS 2)。
Hepatology. 2019 Oct;70(4):1336-1348. doi: 10.1002/hep.30561. Epub 2019 Mar 15.
7
Effects of Fibrinogen Levels and Platelet Counts on Viscoelastic Testing in Cirrhotic Patients.纤维蛋白原水平和血小板计数对肝硬化患者黏弹性检测的影响
J Crit Care Med (Targu Mures). 2018 Jul 1;4(3):90-95. doi: 10.2478/jccm-2018-0012. eCollection 2018 Jul.
8
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.血小板计数不能预测肝硬化患者的出血情况:来自 PRO-LIVER 研究的结果。
Am J Gastroenterol. 2018 Mar;113(3):368-375. doi: 10.1038/ajg.2017.457. Epub 2017 Dec 19.
World J Hepatol. 2013 Jan 27;5(1):1-15. doi: 10.4254/wjh.v5.i1.1.
4
Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions.经皮影像引导介入治疗中凝血状态和止血风险围手术期管理的共识指南。
J Vasc Interv Radiol. 2012 Jun;23(6):727-36. doi: 10.1016/j.jvir.2012.02.012. Epub 2012 Apr 17.
5
Fibrinogen replacement therapy: a critical review of the literature.纤维蛋白原替代疗法:文献综述
Blood Transfus. 2012 Jan;10(1):23-7. doi: 10.2450/2011.0015-11. Epub 2011 Nov 15.
6
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?肝硬化患者存在原发性止血缺陷?事实还是虚构?
J Hepatol. 2011 Dec;55(6):1415-27. doi: 10.1016/j.jhep.2011.06.008. Epub 2011 Jun 28.
7
Can thrombelastography be a new tool to assess bleeding risk in patients with idiopathic thrombocytopenic purpura?血栓弹力描记术能否成为评估特发性血小板减少性紫癜患者出血风险的新工具?
Platelets. 2011;22(7):516-20. doi: 10.3109/09537104.2011.571317. Epub 2011 May 11.
8
Reactions Induced by Platelet Transfusions.血小板输注引起的反应。
Transfus Med Hemother. 2008;35(5):354-358. doi: 10.1159/000151350. Epub 2008 Sep 16.
9
Incidence of bleeding following invasive procedures in patients with thrombocytopenia and advanced liver disease.血小板减少和晚期肝病患者在接受有创操作后的出血发生率。
Clin Gastroenterol Hepatol. 2010 Oct;8(10):899-902; quiz e109. doi: 10.1016/j.cgh.2010.06.018. Epub 2010 Jun 30.
10
Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy.肝硬化诱导性凝血障碍患者的凝血酶生成增加。
J Thromb Haemost. 2010 Sep;8(9):1994-2000. doi: 10.1111/j.1538-7836.2010.03937.x.